Janany Sabes @glomerican.bsky.social · 07/08/2026Nephrology vs Internal Medicine Jeopardy, can you guess who won 😜 #meded 000
Reposted by Janany SabesAmerican Journal of Kidney Diseases @ajkd.bsky.social · 29/06/2026In A Few Words essay by Adam Krieger: "Dialysis keeps people alive, but it also consumes them. We cannot dialyze a broken system, and we must not allow that system to dialyze away our vigilance." What We Cannot Dialyze bit.ly/4f6S8ta (FREE) 101
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 20/03/20261/10 Welcome to #TenPostNephJC Can we move beyond slowing CKD → to actually repairing the kidney? Last #NephJC we discussed Rilparencel, a renal autologous cell therapy (REACT) infusion and its effect on eGFR slope. 198
Janany Sabes @glomerican.bsky.social · 16/03/2026excited for today’s AI in Kidney health primer @ Mount Sinai ! @asnkidney.bsky.social 021
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 08/02/2026Hey #NephSky 2/10/26 at 9 pm EST we'll discuss #Flozinating into the Future & Beyond... SGLT2i in kidney transplant recipients. What's the latest evidence of risk/benefit? Do #Flozins act mechanistically the same in de-innervated kidneys? Come chat. www.nephjc.com/news/inifinti-flozins-transplantnephjc.comTo INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients — NephJCThis week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant. 099
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 09/02/2026Here is the VA for the INFINITI study of SGLT2i in transplant patients by @glomerican.bsky.social #NephSky #Flozins #Flozination www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstractnephjc.comINFINITI: The Visual Abstract — NephJCSGLT2i have reshaped cardiorenal care, but kidney transplant recipients have mostly been left out of the story. INFINITI starts to close that gap, testing the safety and physiology of dapagliflozin in... 0129
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 28/01/2026Up next on #NephJC we will be unpacking SGLT2i in transplant recipients👇 journals.lww.com/cja... 094
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 26/01/2026Oh, the weather outside is frightful 🥶🥶 But #NephJC is so delightful, and since you've no place to go #NephSky... Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky Summary by @shelliefravel.bsky.social @salinesolut.bsky.social www.nephjc.com/news/potcastnephjc.comPOTCAST- K+ Pop and Arrhythmia Drop — NephJCThis week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology. 2139
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 14/01/2026⏰2 hours until #NephJC chat Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis 053
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 12/01/2026Wilst thou join us here, where the Sky is Blue? #NephJC On 1/13/26 at 9pm EST 'tis true We shall converse of the great knight's quest, a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️ www.nephjc.com/news/valiant-c3gnephjc.comA VALIANT effort to combat complement disorders with pegcetacoplan — NephJCThis week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN. 095
Janany Sabes @glomerican.bsky.social · 24/12/2025Tis the season for christmas kidney cookies! Happy Holidays 151
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 19/12/20251/10 Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less? pubmed.ncbi.nlm.nih.gov/41201895/ 188
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 15/12/2025Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳 How soon should we withhold dialysis in AKI? We're discussing the LIBERATE-D trial #NephSky This one might just change your mind 🧠🧠 Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social www.nephjc.com/news/liberated-akinephjc.comDialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D — NephJCThis week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover. 21212
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 12/12/2025 1/10 Welcome to #TenPostNephJC Last #NephJC we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈. 188
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 01/12/2025Maybe the most shocking study from #KidneyWk. 🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊? www.nephjc.com/news/pisces-fishoilnephjc.comFish Oil in Dialysis: A Big Catch or an Empty Net — NephJCHoly Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring? 02016
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 01/12/2025Holy Mackerel! 🐟 🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST Check out the PISCES VA by @brianrifkin.bsky.social www.nephjc.com/news/piscesvanephjc.comPISCES: The Visual Abstract — NephJCCurious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian... 01411
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 18/11/2025Tonite 11/18/25 on #Bluesky 9pm EST We are discussing ORIGIN3 and atacicept in IgAN. APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻) It's going to be Wicked good. 🧙♀️ #NephJC Summary by @notjustdialysis.bsky.social www.nephjc.com/news/atacicept-origin3-gtfb36nephjc.comAttacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJCThis week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN. 0128
Reposted by Janany SabesAmerican Journal of Preventive Cardiology @ajpcardio.bsky.social · 30/10/2025🚨 New study alert: The American Heart Association’s latest “Cardiovascular-Kidney-Metabolic Syndrome” (CKM) metrics reveal major implications for life expectancy in U.S. adults. Dive into the full life-table analysis 👉 ow.ly/MtOT50XkE9P #CardioSky #MedSky 054
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 28/10/2025The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...nephjc.com2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJCThis week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy 12216
Janany Sabes @glomerican.bsky.social · 27/10/2025Hap-Pee Halloween Friends !! #kidneyjokes #kidneypuns #halloween2025 000
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 27/10/2025⏩ Next #NephJC is on IgA nephropathy @kdigo.org guideline 🎨 Nice visual summary by @roxnonna23.bsky.social www.nephjc.com/news/2025/10...nephjc.comKDIGO 2025 IgA guidelines - Visual Abstract — NephJCKDIGO 2025 is here. IgAN management is evolving with precision risk tools, new therapies, and a stronger focus on kidney protection. Check out the visual abstract created by Natalia Nombera 02016
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 22/10/20251/10 Last #NephJC we tried to answer the question whether protein supplementation increases health related QoL 🥩💊#TenPostNephJC . Read the article 👇 pubmed.ncbi.nlm.nih.... 186
Reposted by Janany SabesEdgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 29/09/2025Decision support for PICC Line placement in patients with CKD ca. 2023 #Nephpearls #VascularAccessPearls #NephSky #VisualGraphic by @brianrifkin.bsky.social 👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/ 143
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 29/09/2025Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC www.nephjc.com/news/chimera-tolerance-njqe334nephjc.comChimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression? — NephJCThis week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients. 01712
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 22/09/2025It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drivenephjc.comNephJC 2025 Fall Pledge Drive — NephJCHelp keep NephJC a vital, original, and unbiased source of medical education. 01613
Reposted by Janany Sabesglomcon.org @glomcon.org · 28/07/2025#GlomConHawaii 2025 🌴🌊 session: EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement Register here 👉 glomconhawaii.org #GlomConHawaii2025 #GlomConHawaii #GlomCon 101
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 16/09/2025❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky www.nephjc.com/news/2025/9/ahaacc-htnguidenephjc.comThe AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJCNew updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu... 01914
Reposted by Janany SabesSwapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 16/09/2025Agree with this algorithm from evidence.nejm.org/doi/full/10.... ($$$ or sub reqd) Flozinate and Glipinate Metformin only if these are not appropriate or possible All else comes later 283
Reposted by Janany SabesBrian Rifkin @brianrifkin.bsky.social · 01/09/2025Join us #NephJC #NephSky 224
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 01/09/2025Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social www.nephjc.com/news/2025/8/...nephjc.comThe ACHIEVE visual abstract — NephJCthe use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial. 1106
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 06/08/2025T0b Expert opinion—not RCTs—has dominated guidelines on phosphorus control in ESRD for decades. Why? Because phosphate feels like a villain... but is it really? 🦹♂️ I can feel it in my bones. #NephJC 282
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 23/07/2025Check the insightful #NephJC summary by Akshaya Jayachandran @nephromommy-akshu.bsky.social, Natalia Nombera @roxnonna23.bsky.social, Janany Sabescumar @glomerican.bsky.social www.nephjc.com/news/... 193
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 21/07/2025On 7/22/25 at 9pm EST only on Bluesky! #NephSky #MedSky join us for a lively discussion. We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC www.nephjc.com/news/egfrdiffnephjc.comMind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJCThis week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine). 03822
Reposted by Janany SabesAlicja Rosołowska @alunieczka.bsky.social · 06/07/2025As always the @nephjc.bsky.social summer book turns out to be a great and fascinating read. Highly recommended. 0147
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 07/07/2025🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social ⏰Chat happening on July 8, 9 pm EST www.nephjc.com/news/2025/7/...nephjc.comCONFIDENCE Visual Abstract — NephJCCheck out the beautiful visual abstract made by NephJC intern Michelle Fravel . 11714
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 25/06/20251/10 Last #NephJC we discussed tacrolimus (TAC) versus mycophenolate mofetil (MMF) for the treatment of pediatric nephrotic syndrome. A first👶to👶immunosuppression study for SSNS in kids #TenPostNephJC . Read the articles 👇 pmc.ncbi.nlm.nih.gov/articles/PMC... 179
Reposted by Janany SabesSwapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 21/06/2025The class of 2025, #NephJC interns www.nephjc.com/news/2025/6/... 33417
Janany Sabes @glomerican.bsky.social · 17/06/2025Another year another group of fellows leave the nest! Congratulations Annuj and Mumin! 010
Reposted by Janany SabesNephrology Journal Club @nephjc.bsky.social · 28/05/2025 Major Trials in the use of ASIs targeting difficult-to-control hypertension #NephJC 1179
Reposted by Janany SabesStephanie Torres @stephanietr612.bsky.social · 15/06/2025NephJC Internship 2025 Kick-Off! Let's do this!! @nephjc.bsky.social 095
Janany Sabes @glomerican.bsky.social · 21/05/2025First collaborative Nephrology/Endocrinology Shark Tank, so proud of our fellows and thanks to our panelist of expert judges! 010
Janany Sabes @glomerican.bsky.social · 06/03/2025Women in Medicine Book Club event and the lovely author Dr. Jessi Gold #HowDoYouFeel 000
Reposted by Janany SabesBrendon Neuen @brendonneuen.bsky.social · 12/12/2024Prevent kidney failure to reduce carbon emissions ♻️ 🍃 🏭 Our new analysis of CREDENCE assessing environmental impacts from ⬇️ hospitalisations & dialysis 🏥 with SGLT2i SGLT2i ⬇️ greenhouse gas emissions from inpatient bed days & dialysis by 20% (39 kg CO2e per yr) www.thelancet.com/journals/lan... 0127
